Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia.

Trial Profile

Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Dec 2011

At a glance

  • Drugs Amoxicillin/clavulanic acid; Azithromycin
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Acronyms PROSTO
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Dec 2011 Actual patient number (30) added as reported by ClinicalTrials.gov.
    • 25 Feb 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top